Synthesis and antimicrobial activity of tetrodecamycin partial structures

Area of Science:

• Synthetic organic chemistry
• Medicinal chemistry
• Antibiotic discovery

Background:

• The polyketide antibiotic tetrodecamycin is a novel compound with potential therapeutic applications.
• Developing efficient synthetic routes to complex natural products is crucial for drug discovery.
• Understanding structure-activity relationships is essential for optimizing antibiotic efficacy.

Purpose of the Study:

• To develop an efficient synthetic strategy for the core structure of tetrodecamycin.
• To synthesize and evaluate novel analogues and derivatives of tetrodecamycin for biological activity.
• To investigate the role of specific structural features, such as the exo-methylene moiety, in antibacterial and cytotoxic effects.

Main Methods:

• Acid-catalyzed cyclization of a protected tetronate precursor to form the tricyclic core.
• Parallel introduction of cis-diol and exo-methylene functionalities.
• Evaluation of synthesized compounds against Gram-positive bacteria (Staphylococcus aureus, Enterococcus faecalis) and human leukemia cell lines (HL-60, Jurkat T-cells).

Main Results:

• An efficient synthetic route to tetrodecamycin core structure 5 was established.
• Analogue 6 and derivative 27 exhibited significant antibacterial activity against Staphylococcus aureus and Enterococcus faecalis (MICs 4-16 microg mL(-1)).
• The observed antibacterial activities were paralleled by cytotoxicity against leukemia cell lines (IC(50) 10-23 microM), with the exo-methylene group being critical.

Conclusions:

• The developed synthetic approach provides access to the tetrodecamycin core and its analogues.
• Analogue 6 and derivative 27 represent promising leads for novel antibiotics with dual antibacterial and cytotoxic properties.
• The exo-methylene moiety is essential for the observed biological activities, highlighting its importance in the mechanism of action.